Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0001127602-24-016375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-22 | TMO | Keith R. Alexandra | Dir | A - Grant | $0.00 | +339 | 1,538 | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | A | A | 339 | $0.00 | 1,538 | D | — | — |